| December 7, 2016 | Israeli laparoscopy company Gordian Surgical has closed a $2.25 million financing round. German medical device company, B. Braun Melsungen AG led the investment round with €1 million, with the remainder from current shareholders and three VC funds, two of which are Chinese funds. Gordian Surgical was founded in 2012 by CEO Zvi Pe’er and is a Trendlines Group Medical portfolio company based at the Misgav Business Center in the Western Galilee. Gordian also announced it has received US Food and Drug Administration (FDA) regulatory clearance for its TroClose1200, an innovative trocar with integrated closure system for the suturing of abdominal wall incisions during laparoscopic surgical procedures. The FDA approval follows Gordian’s receipt of CE Mark certification in September.